Massachusetts officials this week enacted restrictions on the prescribing of the potent painkiller Zohydro after their attempt to ban use of the medication was headed for failure.
The Food and Drug Administration (FDA) advisory committee unanimously voted against the approval of Moxduo, the first drug that combines morphine and oxycodone into one capsule
A decision this month by the Alabama Supreme Court led to an outcry from groups advocating substance use treatment services for pregnant women.
Kenneth Blum, PhD, is working with Dominion Diagnostics to advance a genetic risk test for determining individuals' predisposition to addiction.
Vendome Healthcare Media will be hosting both an East Coast and West Coast conference in addition to its National Conference on Addiction Disorders for 2015.
The 40-bed residential recovery house for men in New Jersey focuses on treatment, recovery and community reintegration.
Albuquerque, N.M., City Council member Klarissa Pena says new revenue is needed to offset cuts that the local behavioral health system has experienced in recent years.
A new study, conducted by a team of experts from the Massachusetts General Hospital and Harvard Medical School, shows that repeated marijuana smoking results in two neural regions being misshapen or enlarged.
In issuing her April 15 ruling, U.S. District Court Judge Rya Zobel said the manufacturer of Zohydro is likely to succeed in its attempt for a permanent lifting of Massachusetts' emergency order banning the dispensing of the medication.
As of Saturday, residents of Colorado can get medical marijuana out of an automated vending machine.
Caron Treatment Centers' former chief operating officer has become CEO of Origins Recovery Centers, where former CEO Benjamin Levenson is transitioning to the role of chairman.
The National Institute on Drug Abuse (NIDA) has awarded a $1.1 million, two-year grant from for the launch of the second phase of a project set to impact addictions outcomes to Polaris Health Directions, a Langhorne, Pa.-based behavioral health technology provider.
The award recipient was selected on the merit of her research, which will retrospectively look at discrepancies between self-reported drug use and urine drug testing (UDT) results in an urban, academic primary care-based buprenorphine clinic setting.
BlueCross BlueShield of Massachusetts now limits the quality of prescription narcotic painkillers that its members receive without prior authorization from the company.
Faces & Voices of Recovery announces additional administrative changes, including the impending departure of its program director.